FDA warns of muscle harm when heart drugs combined (Reuters)Reuters - U.S. health officials warned the
public on Friday about the risk of a rare type of muscle injury
seen when the cholesterol drug simvastatin is combined with the
anti-arrhythmia medicine amiodarone.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cholesterol_drugs_dc.html